Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Omik Bioscience AB
AB
Active
Org 5567643902
Ole Römers Väg 12, 223 63
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2008 · 17 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Omik Bioscience AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
179
139
0
78
82
Staff expenses
−129
−68
—
−0
—
EBITDA
−13
1
−49
36
53
Depreciation & amort.
—
—
−32
−32
−8
EBIT
−13
1
−81
4
45
Net financials
0
0
—
—
—
Profit before tax
−13
1
−81
4
45
Tax
—
−0
−0
—
−0
Net profit
−13
1
−81
4
45
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
213
205
215
225
184
Equity
215
228
99
180
176
Long-term debt
—
—
0
—
0
Short-term debt
−2
−23
116
45
8
Total debt
−2
−23
116
45
8
Financial ratios
5-year trend
EBITDA margin
−7,3 %
This company
15,8 %
Market median
This company
Market median
146% below market
2021
2025
Equity ratio
101,1 %
This company
38,2 %
Market median
This company
Market median
165% above market
2021
2025
Return on equity
−6,1 %
This company
18,4 %
Market median
This company
Market median
133% below market
2021
2025
Net profit margin
−7,3 %
This company
8,1 %
Market median
This company
Market median
190% below market
2021
2025
Asset turnover
0,84×
This company
1,12×
Market median
This company
Market median
25% below market
2021
2025
Debt / equity
−0,01×
This company
0,62×
Market median
This company
Market median
102% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
More on Omik Bioscience AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
